BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3123900)

  • 21. New use approved for Vioxx.
    FDA Consum; 2002; 36(4):3. PubMed ID: 12184302
    [No Abstract]   [Full Text] [Related]  

  • 22. Are selective COX-2 inhibitors as effective as NSAIDs in patients with rheumatoid arthritis?
    Smucny J; Chai G
    Am Fam Physician; 2004 Feb; 69(3):595-6. PubMed ID: 14971842
    [No Abstract]   [Full Text] [Related]  

  • 23. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
    Beltrán B; Moreno L; Esplugues JV
    Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F; Harrell K; Fischer R
    South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-steroidal anti-inflammatory agents and cyclooxygenases].
    Vergne P; Bertin P; Bonnet C; Rigaud M; Treves R
    Therapie; 1996; 51(6):639-46. PubMed ID: 9164000
    [No Abstract]   [Full Text] [Related]  

  • 27. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment advances in rheumatoid arthritis.
    Arriola ER; Lee NP
    West J Med; 1999 May; 170(5):278-81. PubMed ID: 10379219
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rofecoxib: its efficacy in rheumatoid arthritis and acute pain].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):47-8. PubMed ID: 15098376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The comparative efficacy of reaferon and methotrexate in rheumatoid arthritis].
    Seĭlanov LS; Balabanova RM; Denisov LA
    Ter Arkh; 1990; 62(5):41-4. PubMed ID: 2396216
    [No Abstract]   [Full Text] [Related]  

  • 31. COX-2 inhibitors.
    Brooks PM; Day RO
    Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psoriasis and non steroidal anti-inflammatory agents].
    Ferrier MC; Souteyrand P
    Ann Dermatol Venereol; 1992; 119(8):591-5. PubMed ID: 1485768
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis.
    Pablos JL
    Arthritis Rheum; 2002 Nov; 46(11):3102. PubMed ID: 12428257
    [No Abstract]   [Full Text] [Related]  

  • 34. The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis.
    Inglis JJ; Criado G; Andrews M; Feldmann M; Williams RO; Selley ML
    Rheumatology (Oxford); 2007 Sep; 46(9):1428-32. PubMed ID: 17644821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 36. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 37. [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis].
    Chen Z; Li RL; Tu SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):183-6. PubMed ID: 19382484
    [No Abstract]   [Full Text] [Related]  

  • 38. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy with rofecoxib. Decreasing risk by controlled COX-2 inhibitor administration].
    MMW Fortschr Med; 2000 Nov; 142(48):64-5. PubMed ID: 11144940
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of tenidap and nonsteroidal antiinflammatory drugs on the response of cultured human T cells to interleukin 2 in rheumatoid arthritis.
    Hall VC; Wolf RE
    J Rheumatol; 1997 Aug; 24(8):1467-70. PubMed ID: 9263136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.